New Delhi, Oct. 31 -- Dubai, UAE - Niner Pharma, one of the fastest-growing pharmaceutical companies in the GCC region, is deepening its innovation focus in the wellness and cosmetic science sectors. The company has announced a significant expansion of its research and development portfolio, with work currently underway on the creation of 125 new peptide molecules aimed at wellness and cosmetic applications.

Under the leadership of Mr. Jamie Balaji Rao , Founder of Niner Pharma, the move underscores Niner Pharma's strategic intent to diversify beyond traditional pharmaceuticals, securing a formidable foothold in the fast-evolving peptide and wellness market. Peptides, short chains of amino acids known for their potential in skin rejuvena...